Technical Analysis for PRTG - Portage Biotech Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
20 DMA Resistance | Bearish | 4.55% | |
Calm After Storm | Range Contraction | 4.55% | |
Narrow Range Bar | Range Contraction | 4.55% | |
Wide Bands | Range Expansion | 4.55% | |
Gapped Up | Strength | 4.55% | |
Fell Below 20 DMA | Bearish | 4.55% |
Alert | Time |
---|---|
20 DMA Resistance | about 14 hours ago |
Rose Above 20 DMA | about 15 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
Rose Above 10 DMA | about 15 hours ago |
Up 5% | about 15 hours ago |
Get a Trading Assistant
- Earnings date: 02/28/2024
Portage Biotech Inc. Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Antiviral Drug Interferon Biotechnology Products Acute Kidney Injury Natural Killer T Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.4 |
52 Week Low | 0.34 |
Average Volume | 60,474 |
200-Day Moving Average | 2.00 |
50-Day Moving Average | 0.74 |
20-Day Moving Average | 0.57 |
10-Day Moving Average | 0.56 |
Average True Range | 0.12 |
RSI (14) | 44.75 |
ADX | 12.36 |
+DI | 24.34 |
-DI | 17.55 |
Chandelier Exit (Long, 3 ATRs) | 0.44 |
Chandelier Exit (Short, 3 ATRs) | 0.69 |
Upper Bollinger Bands | 0.70 |
Lower Bollinger Band | 0.44 |
Percent B (%b) | 0.53 |
BandWidth | 45.27 |
MACD Line | -0.05 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.0156 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.73 | ||||
Resistance 3 (R3) | 0.73 | 0.69 | 0.70 | ||
Resistance 2 (R2) | 0.69 | 0.65 | 0.69 | 0.69 | |
Resistance 1 (R1) | 0.63 | 0.63 | 0.66 | 0.63 | 0.68 |
Pivot Point | 0.59 | 0.59 | 0.61 | 0.59 | 0.59 |
Support 1 (S1) | 0.53 | 0.55 | 0.56 | 0.53 | 0.47 |
Support 2 (S2) | 0.49 | 0.53 | 0.49 | 0.46 | |
Support 3 (S3) | 0.43 | 0.49 | 0.45 | ||
Support 4 (S4) | 0.43 |